相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients
Klaus Munkholm et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation
Hussein Kadhem Al-Hakeim et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder
Elisabet Alcocer-Gomez et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Inflammatory and Metabolic Dysregulation and the 2-Year Course of Depressive Disorders in Antidepressant Users
Nicole Vogelzangs et al.
NEUROPSYCHOPHARMACOLOGY (2014)
The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery
Johan Dahl et al.
PSYCHONEUROENDOCRINOLOGY (2014)
Elevated serumlevels of TNF-α, IL-6 and IL-18 in chronic schizophrenic patients
Yayan Luo et al.
SCHIZOPHRENIA RESEARCH (2014)
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Undine E. Lang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder
Reiji Yoshimura et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2013)
Gray colored glasses: Is major depression partially a sensory perceptual disorder?
Paul J. Fitzgerald
JOURNAL OF AFFECTIVE DISORDERS (2013)
Interleukin-1β is associated with depressive episode in major depression but not in bipolar disorder
Rosana Mota et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Impact of Antidepressants on Cytokine Production of Depressed Patients in Vitro
Alexander Munzer et al.
TOXINS (2013)
Circulating cytokine concentrations are not associated with major depressive disorder in a community-based cohort
Gunnar Einvik et al.
GENERAL HOSPITAL PSYCHIATRY (2012)
Promoter variants in IL18 are associated with onset of depression in patients previously exposed to stressful-life events
Eva Haastrup et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
Seyed-Hesameddin Abbasi et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression
Yang Liu et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology
Mei Hong Xiu et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features
Dalibor Karlovic et al.
PSYCHIATRY RESEARCH (2012)
Association of Plasma Interleukin-18 Levels with Emotion Regulation and μ-Opioid Neurotransmitter Function in Major Depression and Healthy Volunteers
Alan R. Prossin et al.
BIOLOGICAL PSYCHIATRY (2011)
Grand challenges in global mental health
Pamela Y. Collins et al.
NATURE (2011)
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
Jonas Hannestad et al.
NEUROPSYCHOPHARMACOLOGY (2011)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Inflammatory Biomarkers in 70 Depressed Inpatients With and Without the Metabolic Syndrome
Sara Zeugmann et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Interleukin 18 in the CNS
Silvia Alboni et al.
JOURNAL OF NEUROINFLAMMATION (2010)
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
C. L. Raison et al.
MOLECULAR PSYCHIATRY (2010)
The serum interleukin-18 is a potential marker for development of post-stroke depression
Lingli Yang et al.
NEUROLOGICAL RESEARCH (2010)
Role of Microglia in Neurotrauma
David J. Loane et al.
NEUROTHERAPEUTICS (2010)
Overnight Changes of Immune Parameters and Catecholamines Are Associated With Mood and Stress
Winfried Rief et al.
PSYCHOSOMATIC MEDICINE (2010)
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller et al.
BIOLOGICAL PSYCHIATRY (2009)
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Elisa Brietzke et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression
Michael Maes et al.
METABOLIC BRAIN DISEASE (2009)
Evidence for a cytokine model of cognitive function
J. McAfoose et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Reiji Yoshimura et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study
Fabiano G. Nery et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Systemic infections and inflammation affect chronic neurodegeneration
V. Hugh Perry et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Twenty years of research on cytokine-induced sickness behavior
Robert Dantzer et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Cytokine profiles in women with different subtypes of major depressive disorder
A. H. Marques-Deak et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Microglial activation and its implications in the brain diseases
S. Thameem Dheen et al.
CURRENT MEDICINAL CHEMISTRY (2007)
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression:: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
N Müller et al.
MOLECULAR PSYCHIATRY (2006)
Cost of disorders of the brain in Europe
P Andlin-Sobocki et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
IL-18: a key player in neuroinflammation and neurodegeneration?
U Felderhoff-Mueser et al.
TRENDS IN NEUROSCIENCES (2005)
Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction
CL Raison et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Increase in interleukin-1 beta in late-life depression
AJ Thomas et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Raised plasma levels of tumor necrosis factor α in patients with depression -: Normalization during electroconvulsive therapy
KA Hestad et al.
JOURNAL OF ECT (2003)
Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder
C Tuglu et al.
PSYCHOPHARMACOLOGY (2003)
Interleukin-18 and CD30 serum levels in patients with moderate-severe depression
RA Merendino et al.
MEDIATORS OF INFLAMMATION (2002)
Paroxetine for the prevention of depression induced by high-dose interferon alfa
DL Musselman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Neural and humoral pathways of communication from the immune system to the brain:: parallel or convergent?
R Dantzer et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2000)
分享论文
